MedPath

Ebselen

Generic Name
Ebselen
Drug Type
Small Molecule
Chemical Formula
C13H9NOSe
CAS Number
60940-34-3
Unique Ingredient Identifier
40X2P7DPGH

Overview

Ebselen has been investigated for the treatment and basic science of Meniere's Disease, Type 2 Diabetes Mellitus, and Type 1 Diabetes Mellitus.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
SPI-1005 for the Treatment of Meniere's Disease (Open Label)
2025/03/05
NCT06859788
Phase 3
Not yet recruiting
Sound Pharmaceuticals, Incorporated
SPI-1005 in Adults Receiving Cochlear Implant
2024/04/01
NCT06340633
Phase 2
Not yet recruiting
Sound Pharmaceuticals, Incorporated
IMPase in Treatment-resistant Depression
2021/11/11
NCT05117710
Phase 1
Recruiting
University of Oxford
SPI-1005 for the Treatment of Meniere's Disease
2020/12/21
NCT04677972
Phase 3
Completed
Sound Pharmaceuticals, Incorporated
SPI-1005 Treatment in Moderate COVID-19 Patients
2020/07/23
NCT04484025
Phase 2
ENROLLING_BY_INVITATION
Sound Pharmaceuticals, Incorporated
SPI-1005 Treatment in Severe COVID-19 Patients
2020/07/23
NCT04483973
Phase 2
ENROLLING_BY_INVITATION
Sound Pharmaceuticals, Incorporated
Ebselen as an add-on Treatment in Hypo/Mania
2017/01/06
NCT03013400
Phase 2
Completed
University of Oxford
Study to Evaluate SPI-1005 in Adults With Meniere's Disease
2015/11/11
NCT02603081
Phase 1
Completed
Sound Pharmaceuticals, Incorporated
Study to Evaluate the Safety and Pharmacokinetics of SPI-1005
2011/10/17
NCT01452607
Phase 1
Completed
Sound Pharmaceuticals, Incorporated
Signaling Mechanisms and Vascular Function in Patients With Diabetes Mellitus
2008/09/30
NCT00762671
Phase 2
Completed
Brigham and Women's Hospital

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
No NMPA approvals found for this drug.

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.

Help Us Improve

Your feedback helps us provide better drug information and insights.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.